Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990603979> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W1990603979 endingPage "12" @default.
- W1990603979 startingPage "8" @default.
- W1990603979 abstract "Objective: To evaluate the value of erythropoietin alpha (epoetin) administration, as an alternative treatment of anemia in the operable breast cancer patients. Methods: This is a multicenter phase III randomized clinical trial to evaluate the value of epoetin administration among anemic breast cancer patients who are undergoing anthracyclin-based adjuvant chemotherapy. Sixty four patients were incuded in this trial with initial hemoglobin (Hb) level of 10–12 g/dL. The patients were randomly distributed into two groups: one group received aministration of 40,000 IU epoetin/week for six times a week after operation and the other did not. In the third week after the operation, both groups were started on a 6 cycles of adjuvant chemotherapy with three weeks intervals. Hb levels were evaluated during every chemotherapy cycle. Results: The Hb levels in the epoetin group were always above 10 g/dL up until the end of the sixth chemotherapy cycle or until the twenty first week post operation without blood transfusion. Conclusions: The administration of epoetin 3 weeks prior and 3 weeks after the first cycles of chemotherapy, maintains a sufficient/normal Hb level in breast cancer patients receiving anthracycline-based chemotherapy. Keywords: Anthracyclin-based chemotherapy, breast cancer, erythropoietin alpha DOI: 10.15850/ijihs.v1n1.102" @default.
- W1990603979 created "2016-06-24" @default.
- W1990603979 creator A5046693681 @default.
- W1990603979 creator A5049157306 @default.
- W1990603979 creator A5056891630 @default.
- W1990603979 creator A5059493933 @default.
- W1990603979 creator A5086606759 @default.
- W1990603979 date "2013-01-01" @default.
- W1990603979 modified "2023-09-25" @default.
- W1990603979 title "STRATEGY FOR THE USE OF ERYTHROPOETIN ALPHA TO MAINTAIN HEMOGLOBIN LEVEL IN BREAST CANCER PATIENT TREATED WITH ANTHRACYCLINE-BASE OF ADJUVANT CHEMOTHERAPY" @default.
- W1990603979 cites W1885881044 @default.
- W1990603979 cites W1926396371 @default.
- W1990603979 cites W2004502886 @default.
- W1990603979 cites W2101364791 @default.
- W1990603979 cites W2133170052 @default.
- W1990603979 cites W2156591199 @default.
- W1990603979 cites W2163830215 @default.
- W1990603979 cites W2168236050 @default.
- W1990603979 doi "https://doi.org/10.15850/ijihs.v1n1.102" @default.
- W1990603979 hasPublicationYear "2013" @default.
- W1990603979 type Work @default.
- W1990603979 sameAs 1990603979 @default.
- W1990603979 citedByCount "0" @default.
- W1990603979 crossrefType "journal-article" @default.
- W1990603979 hasAuthorship W1990603979A5046693681 @default.
- W1990603979 hasAuthorship W1990603979A5049157306 @default.
- W1990603979 hasAuthorship W1990603979A5056891630 @default.
- W1990603979 hasAuthorship W1990603979A5059493933 @default.
- W1990603979 hasAuthorship W1990603979A5086606759 @default.
- W1990603979 hasBestOaLocation W19906039791 @default.
- W1990603979 hasConcept C121608353 @default.
- W1990603979 hasConcept C126322002 @default.
- W1990603979 hasConcept C141071460 @default.
- W1990603979 hasConcept C143998085 @default.
- W1990603979 hasConcept C2776164570 @default.
- W1990603979 hasConcept C2776694085 @default.
- W1990603979 hasConcept C2776802502 @default.
- W1990603979 hasConcept C2777863537 @default.
- W1990603979 hasConcept C2778248108 @default.
- W1990603979 hasConcept C2778534260 @default.
- W1990603979 hasConcept C530470458 @default.
- W1990603979 hasConcept C71924100 @default.
- W1990603979 hasConcept C90924648 @default.
- W1990603979 hasConceptScore W1990603979C121608353 @default.
- W1990603979 hasConceptScore W1990603979C126322002 @default.
- W1990603979 hasConceptScore W1990603979C141071460 @default.
- W1990603979 hasConceptScore W1990603979C143998085 @default.
- W1990603979 hasConceptScore W1990603979C2776164570 @default.
- W1990603979 hasConceptScore W1990603979C2776694085 @default.
- W1990603979 hasConceptScore W1990603979C2776802502 @default.
- W1990603979 hasConceptScore W1990603979C2777863537 @default.
- W1990603979 hasConceptScore W1990603979C2778248108 @default.
- W1990603979 hasConceptScore W1990603979C2778534260 @default.
- W1990603979 hasConceptScore W1990603979C530470458 @default.
- W1990603979 hasConceptScore W1990603979C71924100 @default.
- W1990603979 hasConceptScore W1990603979C90924648 @default.
- W1990603979 hasIssue "1" @default.
- W1990603979 hasLocation W19906039791 @default.
- W1990603979 hasLocation W19906039792 @default.
- W1990603979 hasOpenAccess W1990603979 @default.
- W1990603979 hasPrimaryLocation W19906039791 @default.
- W1990603979 hasRelatedWork W1970789493 @default.
- W1990603979 hasRelatedWork W1991284991 @default.
- W1990603979 hasRelatedWork W2020150632 @default.
- W1990603979 hasRelatedWork W2040029744 @default.
- W1990603979 hasRelatedWork W2060861099 @default.
- W1990603979 hasRelatedWork W2386717267 @default.
- W1990603979 hasRelatedWork W2591616149 @default.
- W1990603979 hasRelatedWork W2791179561 @default.
- W1990603979 hasRelatedWork W4212973790 @default.
- W1990603979 hasRelatedWork W2418834791 @default.
- W1990603979 hasVolume "1" @default.
- W1990603979 isParatext "false" @default.
- W1990603979 isRetracted "false" @default.
- W1990603979 magId "1990603979" @default.
- W1990603979 workType "article" @default.